atenolol has been researched along with Central Nervous System Diseases in 3 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taylor, EA | 1 |
| Jefferson, D | 1 |
| Carroll, JD | 1 |
| Turner, P | 1 |
| Kirk, CA | 1 |
| Cove-Smith, R | 1 |
| Conant, J | 1 |
| Engler, R | 1 |
| Janowsky, D | 1 |
| Maisel, A | 1 |
| Gilpin, E | 1 |
| LeWinter, M | 1 |
2 trials available for atenolol and Central Nervous System Diseases
| Article | Year |
|---|---|
A comparison between atenolol and metoprolol in respect of central nervous system side effects.
Topics: Atenolol; Central Nervous System Diseases; Double-Blind Method; Humans; Hypertension; Metoprolol | 1983 |
Central nervous system side effects of beta-adrenergic blocking agents with high and low lipid solubility.
Topics: Adult; Affect; Aged; Atenolol; Central Nervous System Diseases; Humans; Lipids; Male; Middle Aged; M | 1989 |
1 other study available for atenolol and Central Nervous System Diseases
| Article | Year |
|---|---|
Cerebrospinal fluid concentrations of propranolol, pindolol and atenolol in man: evidence for central actions of beta-adrenoceptor antagonists.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Central Nervous System; Central Nervous System D | 1981 |